GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DRI Healthcare Trust (TSX:DHT.U) » Definitions » 3-Year RORE %

DRI Healthcare Trust (TSX:DHT.U) 3-Year RORE % : 68.01% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is DRI Healthcare Trust 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. DRI Healthcare Trust's 3-Year RORE % for the quarter that ended in Dec. 2023 was 68.01%.

The industry rank for DRI Healthcare Trust's 3-Year RORE % or its related term are showing as below:

TSX:DHT.U's 3-Year RORE % is ranked better than
89.03% of 1003 companies
in the Drug Manufacturers industry
Industry Median: 1.82 vs TSX:DHT.U: 68.01

DRI Healthcare Trust 3-Year RORE % Historical Data

The historical data trend for DRI Healthcare Trust's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DRI Healthcare Trust 3-Year RORE % Chart

DRI Healthcare Trust Annual Data
Trend Dec21 Dec22 Dec23
3-Year RORE %
- - 68.01

DRI Healthcare Trust Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 68.01

Competitive Comparison of DRI Healthcare Trust's 3-Year RORE %

For the Drug Manufacturers - Specialty & Generic subindustry, DRI Healthcare Trust's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DRI Healthcare Trust's 3-Year RORE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DRI Healthcare Trust's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where DRI Healthcare Trust's 3-Year RORE % falls into.



DRI Healthcare Trust 3-Year RORE % Calculation

DRI Healthcare Trust's 3-Year RORE % for the quarter that ended in Dec. 2023 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 2.23-0.61 )/( 3.15-0.768 )
=1.62/2.382
=68.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2023 and 3-year before.


DRI Healthcare Trust  (TSX:DHT.U) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


DRI Healthcare Trust 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of DRI Healthcare Trust's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


DRI Healthcare Trust (TSX:DHT.U) Business Description

Traded in Other Exchanges
Address
100 King Street West, 1 First Canadian Place, Suite 7250, Toronto, ON, CAN, M5X 1B1
DRI Healthcare Trust is a pioneer in global pharmaceutical royalty monetization with a more than 30-year history of accelerating innovation by providing capital to inventors, academic institutions, and biopharma companies. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world.

DRI Healthcare Trust (TSX:DHT.U) Headlines

No Headlines